A gene detection platform utilizing solid-state nanopore technology for genomic analysis. This system enables rapid and accurate DNA sequencing for clinical and research applications. The technology represents an advanced approach to molecular diagnostics.
Manufactured by
China
Suzhou Linaxin Biotechnology Co., Ltd. manufactures solid-state nanopore gene detection equipment, including solid-state nanopore detectors, nanopore chips, and supporting microfluidic devices. The company also produces medical diagnostic products for gastrointestinal and cancer early screening applications. No certification information was provided in the available content.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
AB ANALITICA Srl
Italy · 1 relevant product
Hicomp Microtech(Suzhou) Co., Ltd.
China · 2 relevant products
GENETRON HEALTH (BEIJING) CO., LTD
China · 1 relevant product
18 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →6 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 25 closest product alternatives
AB ANALITICA Srl · Italy
Next Generation Sequencing platform for comprehensive genomic and molecular analysis. This advanced sequencing technology enables high-throughput analysis of DNA and RNA samples.
Hicomp Microtech(Suzhou) Co., Ltd. · China
Specialized microfluidic platforms designed to support efficient nucleic acid processing for genomic sequencing applications.
GENETRON HEALTH (BEIJING) CO., LTD · China
Comprehensive genomic sequencing platform for cancer diagnosis and characterization. Utilizes next-generation sequencing technology to identify genetic mutations and alterations in tumor samples. Supports treatment selection and clinical decision-making for oncology patients.
22 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products